Unicycive Therapeutics Stock Forecast - Polynomial Regression
| UNCY Stock | USD 1.07 0.08 6.96% |
The Polynomial Regression forecasted value of Unicycive Therapeutics on the next trading day is expected to be 1.05 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 4.31. Unicycive Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Unicycive Therapeutics stock prices and determine the direction of Unicycive Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Unicycive Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Unicycive Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Unicycive Therapeutics' systematic risk associated with finding meaningful patterns of Unicycive Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Unicycive Therapeutics to cross-verify your projections. Unicycive |
Most investors in Unicycive Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Unicycive Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Unicycive Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Unicycive Therapeutics polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Unicycive Therapeutics as well as the accuracy indicators are determined from the period prices. Unicycive Therapeutics Polynomial Regression Price Forecast For the 24th of April
Given 90 days horizon, the Polynomial Regression forecasted value of Unicycive Therapeutics on the next trading day is expected to be 1.05 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.31.Please note that although there have been many attempts to predict Unicycive Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Unicycive Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Unicycive Therapeutics Stock Forecast Pattern
| Backtest Unicycive Therapeutics | Unicycive Therapeutics Price Prediction | Buy or Sell Advice |
Unicycive Therapeutics Forecasted Value
In the context of forecasting Unicycive Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Unicycive Therapeutics' downside and upside margins for the forecasting period are 0.01 and 6.64, respectively. We have considered Unicycive Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Unicycive Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Unicycive Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.5423 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0706 |
| MAPE | Mean absolute percentage error | 0.0538 |
| SAE | Sum of the absolute errors | 4.3063 |
Predictive Modules for Unicycive Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Unicycive Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Unicycive Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Unicycive Therapeutics
For every potential investor in Unicycive, whether a beginner or expert, Unicycive Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Unicycive Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Unicycive. Basic forecasting techniques help filter out the noise by identifying Unicycive Therapeutics' price trends.Unicycive Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Unicycive Therapeutics stock to make a market-neutral strategy. Peer analysis of Unicycive Therapeutics could also be used in its relative valuation, which is a method of valuing Unicycive Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Unicycive Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Unicycive Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Unicycive Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Unicycive Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Unicycive Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Unicycive Therapeutics shares will generate the highest return on investment. By undertsting and applying Unicycive Therapeutics stock market strength indicators, traders can identify Unicycive Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 24541.21 | |||
| Daily Balance Of Power | (0.67) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 1.13 | |||
| Day Typical Price | 1.11 | |||
| Price Action Indicator | (0.10) | |||
| Period Momentum Indicator | (0.08) |
Unicycive Therapeutics Risk Indicators
The analysis of Unicycive Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Unicycive Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting unicycive stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.68 | |||
| Semi Deviation | 4.16 | |||
| Standard Deviation | 5.92 | |||
| Variance | 35.08 | |||
| Downside Variance | 18.96 | |||
| Semi Variance | 17.31 | |||
| Expected Short fall | (6.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Unicycive Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Unicycive Therapeutics' short interest history, or implied volatility extrapolated from Unicycive Therapeutics options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Unicycive Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Unicycive Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unicycive Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unicycive Therapeutics Stock:Check out Historical Fundamental Analysis of Unicycive Therapeutics to cross-verify your projections. For more information on how to buy Unicycive Stock please use our How to Invest in Unicycive Therapeutics guide.Note that the Unicycive Therapeutics information on this page should be used as a complementary analysis to other Unicycive Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Unicycive Stock analysis
When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Unicycive Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Unicycive Therapeutics. If investors know Unicycive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Unicycive Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 0.028 | Return On Assets (1.53) | Return On Equity (6.97) |
The market value of Unicycive Therapeutics is measured differently than its book value, which is the value of Unicycive that is recorded on the company's balance sheet. Investors also form their own opinion of Unicycive Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Unicycive Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Unicycive Therapeutics' market value can be influenced by many factors that don't directly affect Unicycive Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Unicycive Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Unicycive Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Unicycive Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.